Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Harvard Business School
McKesson
Merck
McKinsey

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Staley v. Gilead Sciences, Inc. (N.D. Cal. 2019)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Staley v. Gilead Sciences, Inc. (N.D. Cal. 2019)

Docket   Start Trial Date Filed 2019-05-14
Court District Court, N.D. California Date Terminated
Cause 15:1 Antitrust Litigation Assigned To Edward Milton Chen
Jury Demand Plaintiff Referred To Laurel Beeler
Parties AKROS PHARMA INC.; ANDREW R. SPIELDENNER, PHD; BRENDA EMILY GOODROW; BRISTOL-MYERS SQUIBB COMPANY; E. R. SQUIBB & SONS, LLC; FEDERAL TRADE COMMISSION; FRATERNAL ORDER OF POLICE, FORT LAUDERDALE LODGE 31, INSURANCE TRUST FUND; FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND; GABRIEL MOLINA; GILEAD HOLDINGS, LLC; GILEAD SCIENCES IRELAND UC; GILEAD SCIENCES, INC.; GILEAD SCIENCES, LLC; GREGG S. GONSALVES, PHD; HIV ORGANIZATIONS; JACOB ZYDONIS; JANSSEN R&D IRELAND; JAPAN TOBACCO INC.; JAPAN TOBACCO INTERNATIONAL U.S.A. INC; JASON WALKER; JOHN CARROLL; JOHN DOE; JOHNSON & JOHNSON INC.; JOSH MCDONALD; MICHAEL SNIPE; MICHAEL WARNER; PETER STALEY; PIPE TRADES SERVICES MN WELFARE FUND; ROBERT J. VAZQUEZ; SERVICE EMPLOYEES INTERNATIONAL UNION, LOCAL NO. 1 HEALTH FUND; STEVE FULLER; TEAMSTERS LOCAL 237 RETIREES' BENEFIT FUND; TEAMSTERS LOCAL 237 WELFARE FUND; TROY VAZQUEZ-CAIN
Patents 5,922,695; 5,935,946; 5,977,089; 6,043,230; 6,642,245; 6,703,396; 7,390,791; 7,803,788; 8,754,065; 9,296,769
Attorneys Ada Victoria Anon; Aditya Vijay Kamdar; Alberto Rodriguez; Ashley Lynn Shively; Brian D. Brooks; Brianna Ricque Howard; Bryan Gant; Christopher M. Curran; Cindy Yuanjia Hong; Daniel B. Asimow; Daniel Evan Rubenstein; Daralyn J. Durie; David Floyd McGowan; David Paul Germaine; Donald Sean Nation; Eamon Padraic Kelly; Elizabeth Cheryl Pritzker; Frazar Wright Thomas; Gregory T Arnold; Heather K. McDevitt; Heather Marie Burke; Heidi M Silton; Jayne Arnold Goldstein; Jeremy Kent Ostrander; Jerome W Hoffman; Jessica N. Servais; Joanne Celia Lewers; John Daniel Radice; John Palmer Kern; Jonathan Krasne Levine; Karen Hanson Riebel; Kevin Francis Ruf; Laura Elizabeth Miller; Laura S Shores; Lee Albert; Linda Phyllis Nussbaum; Lionel Z. Glancy; Mark Alan Lemley; Markus H Meier; Matthew C. Weiner; Michael Joseph Gallagher , Jr; Michael Patrick Ols; Natalie Finkelman Bennett; Neal N. Beaton; Nicholas William Shadowen; Paul Hewit Saint-Antoine; Paul Jeffrey Riehle; Peter J. Carney; Phillip Robert Malone; Richard M Brunell; Robert C. Hilliard; Steve D. Shadowen; Steve W. Berman; Thomas J. Yoo; Thomas M. Sobol; W. Henry Huttinger
Firms Arnold & Porter Kaye Scholer LLP; David Paul Germaine; Durie Tangri LLP; Eamon Padraic Kelly; Federal Trade Commission; Glancy Prongay & Murray LLP; Glancy Prongay and Murray LLP; Hagens Berman Sobol Shapiro LLP; Hilliard & Shadowen LLP; Hilliard and Shadowen; Hilliard Shadowen, LLP; Holland & Knight; Holland and Knight LLP; Holland and Knight, LLP; Lockridge Grindal Nauen PLLP; Nussbaum Law Group, P.C.; Pritzker Levine LLP; Radice Law Firm PC; Radice Law Firm, PC; Shepherd Finkelman Miller & Shah; Shepherd Finkelman Miller & Shah LLP; Shepherd Finkelman Miller and Shah LLP; Shepherd, Finkelman, Miller & Shah, LLP; Sperling & Slater, P.C.; Vanek Vickers and Masini PC; White & Case; White & Case LLP; White and Case; White and Case LLP, 3000 El Camino Real
Link to Docket External link to docket
Small Molecule Drugs cited in Staley v. Gilead Sciences, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Staley v. Gilead Sciences, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Staley v. Gilead Sciences, Inc. (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint Gilead’s basic patents claiming TDF and certain methods of using it—patents 26 5,922,695; 5,935,946; 5,977,089…listed patent(s) and/or the patent is invalid and 10 unenforceable. Simply by listing the patents in the…ANDA applicant for patent 15 infringement. If the brand manufacturer brings a patent infringement action…legitimate patent protection or ferret out invalid, unenforceable, or 16 narrow drug patents. 17 18 …even after the 15 patents on them expired. 16 91. Gilead’s patents on TDF, FTC, and TDF External link to document
0000-00-00 118 Complaint Gilead’s basic patents claiming TDF and certain methods of using it—patents 9 5,922,695; 5,935,946; …listed patent(s) and/or the patent is invalid and 23 unenforceable. Simply by listing the patents in the…ANDA applicant for patent 28 infringement. If the brand manufacturer brings a patent infringement action…applied for patents that 26 claim the formulation of TAF with FTC. See, e.g., United States Patent Application…Gilead’s patents protecting TAF can be divided into two groups: 7 Group Patent Patent External link to document
0000-00-00 96 Complaint Gilead’s basic patents claiming TDF and certain methods of using it—patents 14 5,922,695; 5,935,946; 5,977,089…listed patent(s) and/or the patent is invalid and 22 unenforceable. Simply by listing the patents in the…ANDA applicant for patent 27 infringement. If the brand manufacturer brings a patent infringement action…legitimate patent protection or ferret out invalid, unenforceable, or 28 narrow drug patents. …even after the 27 patents on them expired. 28 96. Gilead’s patents on TDF, FTC, and TDF External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
Mallinckrodt
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.